Biggest News Aggregation in the World
📰 Alligator Bioscience News

Page 6 - Alligator Bioscience News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alligator Bioscience. Real-time updates on events, politics, business and more.

Alligator Bioscience AB: Interim report January-March 2021

                                                                                                           High activity during the first quarter "So far, 2021 has been characterized by high activity, with a research collaboration that validates our Discovery concept, and good progress of our clinical programs, with ATOR-1017 and mitazalimab entering clinical efficacy studies this year." Ma...
Hans Peter Ostler Malin Carlsson Marie Svensson Veronica Wallin Anders Ekblom Graham Dixon

The Nomination Committee's proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bioscience AB

The Nomination Committees proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bioscience AB News provided by Share this article STOCKHOLM, April 22, 2021 /PRNewswire/ --  Ahead of the annual general meeting in Alligator Bioscience AB on June 1, 2021, the Nomination Committee announces its proposals regarding Chairman of the board, Vice Chairman of the board and other board members. The Nomination Committee proposes: that the board shall consist of fi...
Uppsala Lan Vastra Gotalands Lan Astra Astrazeneca Jan Lundstr Kirsten Drejer Hans Peter Ostler

Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy

Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy LUND, Sweden, April 15, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research collaboration with MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The research collaboration will lead to ...
Peter Benson Malin Carlsson Aptevo Therapeutics Inc Shanghai Henlius Biotech Inc Macrogenics Inc Research Collaboration

Rockville's MacroGenics Enters Research Collaboration with Sweden's Alligator Bioscience to Develop a Novel Immunotherapy · BioBuzz

LUND, Sweden, April 15, 2021 /PRNewswire/ —   (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research collaboration with MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The research collaboration will lead to the expansion of Alligator’s proprietary patient specific immunotherapy Neo-X-Prime™ by incorporating MacroGenics’...
Peter Benson Malin Carlsson Aptevo Therapeutics Inc Shanghai Henlius Biotech Inc Macrogenics Inc Rockville Macrogenics Enters Research Collaboration
Source: biobuzz.io

Alligator Bioscience postpones the Annual General Meeting to June 1, 2021

Alligator Bioscience postpones the Annual General Meeting to June 1, 2021 News provided by Share this article LUND, Sweden, April 3, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the board of directors has decided to postpone the Annual General Meeting to June 1, 2021, in connection with that Søren Bregenholt takes office as new CEO of Alligator. In light of the ongoing Covid-19 pandemic, and in order to reduce the risk of infection spreading, the b...
Malin Carlsson Aptevo Therapeutics Inc Shanghai Henlius Biotech Inc Nasdaq Stockholm Annual General Meeting Aptevo Therapeutics

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Nasdaq Stockholm AB: Delisting of paid subscription shares in Alligator Bioscience AB (26/21)

The paid subscription shares in Alligator Bioscience AB will be delisted. Last trading day for ATORX BTA will be on February 26, 2021. Instrument: Paid subscription shares --------------------------------------- Short
Alligator Bioscience Issuer Surveillance Nasdaq Stockholm முதலை உயிர் அறிவியல் வழங்குபவர் கண்காணிப்பு நாஸ்டாக் ஸ்டாக்‌ஹோல்ம்

Alligator Bioscience's rights issue oversubscribed

Alligator Biosciences rights issue oversubscribed STOCKHOLM, Jan. 27, 2021 /PRNewswire/ -- Alligator Bioscience AB (publ) ("Alligator" or the "Company") has completed the share issue with pre-emption rights for the Companys shareholders, which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the annual general meeting on May 5, 2020 (the "Rights Issue"). The subscription period ran from and including January 11, 2021 to and including January 2...
United States New Zealand Hong Kong United Kingdom South Africa South Korea

The subscription period in Alligator Bioscience's rights issue commences today

The subscription period in Alligator Biosciences rights issue commences today News provided by Share this article Share this article NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, CANADA, NEW ZEALAND, SOUTH AFRICA, JAPAN, AUSTRALIA, SOUTH KOREA, HONG KONG, SWITZERLAND, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. STOCKHOLM, Jan...
United States New Zealand Hong Kong United Kingdom South Africa South Korea

Alligator Bioscience publishes prospectus in connection with forthcoming rights issue

Alligator Bioscience publishes prospectus in connection with forthcoming rights issue STOCKHOLM, Dec. 30, 2020 /PRNewswire/ -- T he Board of Directors of Alligator Bioscience AB (publ) ("Alligator" or the "Company") has, in connection with the rights issue of shares which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the Annual General Meeting on May 5, 2020 (the "Rights Issue"), prepared a prospectus (the "Prospectus") that today has been a...
United States New Zealand Hong Kong United Kingdom South Africa South Korea

Aptevo Therapeutics Inc. - Consensus Indicates Potential 82.2% Upside

9:52 am Aptevo Therapeutics Inc. found using ticker (APVO) now have 3 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 69 and 64 and has a mean target at 65.67. Given that the stocks previous close was at 36.05 this now indicates there is a potential upside of 82.2%. The day 50 moving average is 39.86 and the 200 day MA is 15.73. The market cap for the company is $156m. Visit the company website at: http://aptevother...
United States Aptevo Therapeutics Inc Aptevo Therapeutics Therapeutics Inc Alligator Bioscience ஒன்றுபட்டது மாநிலங்களில்

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science